Oracle (NYSE:ORCL) Stock Price Down 3.2% – Time to Sell?

Oracle Corporation (NYSE:ORCL) traded down 3.2% on Wednesday . The stock traded as low as $144.23 and last traded at $144.4390. Approximately 22,069,224 shares changed hands during trading, a decline of 25% from the average session volume of 29,318,178 shares. The stock had previously closed at $149.20.

Key Stories Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Expanded AI and healthcare offerings: Oracle introduced an AI-enabled Oncology EHR and new AI capabilities for revenue-cycle management, while its Life Sciences Data Intelligence platform is being expanded with real-world data, analytics and domain-specific AI. These launches could support long-term growth in healthcare and pharmaceutical software. Oracle to Advance Cancer Care with New Oncology EHR
• Positive Sentiment: Research and customer adoption provide commercial validation: The Buck Institute is using Oracle’s health data and analytics to research age-related disease, while U.K. venue Co-op Live is deploying Oracle Simphony Cloud POS and NetSuite. Such announcements reinforce Oracle’s push to expand cloud applications beyond its traditional database business. Oracle and Buck Institute for Research on Aging
• Positive Sentiment: AI infrastructure ecosystem continues to broaden: FlashGrid added support for Oracle AI Database 26ai on native infrastructure-as-a-service clouds, potentially improving adoption of Oracle’s AI-native database platform. Oracle’s reported cloud growth and large backlog also continue to attract bullish analyst commentary. FlashGrid adds support for Oracle AI Database 26ai deployments
• Neutral Sentiment: Wipro partnership targets drug-safety services: Oracle and Wipro will offer managed cloud-based pharmacovigilance services using Oracle Life Sciences Argus. The deal expands Oracle’s addressable market, although its near-term revenue impact is not disclosed. Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services
• Negative Sentiment: Funding and cash-flow concerns remain the main overhang: Reports highlight persistent debt issuance and higher borrowing costs tied to Oracle’s data-center expansion, alongside negative free cash flow. Investors are questioning whether AI demand will generate adequate returns to justify the required capital investment. Oracle Edged Higher While AI Borrowers Pay 37 Extra Basis Points
• Negative Sentiment: Layoffs add execution concerns: More than 500 U.S. cloud-infrastructure employees were reportedly laid off, including engineers, developers, managers and data-center support staff. The cuts may improve efficiency, but they also raise questions about capacity and execution while Oracle is aggressively building its AI cloud business. Revealed: Some of the Oracle cloud roles hit hardest in layoffs

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. UBS Group increased their target price on Oracle from $245.00 to $250.00 and gave the company a “buy” rating in a report on Friday, September 11th. Scotiabank lowered their price objective on Oracle from $241.00 to $215.00 and set a “sector outperform” rating for the company in a research report on Wednesday, September 9th. Citizens Jmp reiterated a “market outperform” rating and issued a $285.00 price objective on shares of Oracle in a report on Wednesday, September 9th. Barclays raised their target price on Oracle from $250.00 to $252.00 and gave the stock an “overweight” rating in a research report on Friday, September 11th. Finally, Citigroup reiterated a “market outperform” rating on shares of Oracle in a research note on Friday, September 11th. Two analysts have rated the stock with a Strong Buy rating, thirty have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Oracle has a consensus rating of “Moderate Buy” and a consensus price target of $252.58.

Oracle Stock Performance

The stock’s 50-day moving average is $142.15 and its 200 day moving average is $160.41. The stock has a market cap of $436.75 billion, a price-to-earnings ratio of 22.64, a P/E/G ratio of 1.06 and a beta of 1.74. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.17 and a quick ratio of 1.17.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating the consensus estimate of $1.74 by $0.18. The business had revenue of $19.34 billion during the quarter, compared to analysts’ expectations of $19.13 billion. Oracle had a return on equity of 48.85% and a net margin of 26.36%.The company’s quarterly revenue was up 29.6% compared to the same quarter last year. During the same period last year, the firm earned $1.47 EPS. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, analysts predict that Oracle Corporation will post 6.67 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Stockholders of record on Friday, October 9th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 9th. Oracle’s dividend payout ratio (DPR) is currently 31.35%.

Insider Activity at Oracle

In other news, CEO Michael Sicilia sold 10,882 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $139.94, for a total value of $1,522,827.08. Following the completion of the sale, the chief executive officer directly owned 149,084 shares in the company, valued at approximately $20,862,814.96. The trade was a 6.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.

Hedge Funds Weigh In On Oracle

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its stake in Oracle by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 37,734,944 shares of the enterprise software provider’s stock worth $7,328,754,000 after purchasing an additional 665,374 shares during the period. Capital Research Global Investors boosted its holdings in Oracle by 29.3% in the fourth quarter. Capital Research Global Investors now owns 30,137,126 shares of the enterprise software provider’s stock worth $5,874,070,000 after purchasing an additional 6,826,299 shares in the last quarter. Norges Bank bought a new position in Oracle during the fourth quarter valued at about $4,336,031,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Oracle by 0.8% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,680,278 shares of the enterprise software provider’s stock worth $2,151,395,000 after buying an additional 123,294 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of Oracle by 8.6% during the 4th quarter. Janus Henderson Group PLC now owns 14,539,366 shares of the enterprise software provider’s stock worth $2,815,242,000 after acquiring an additional 1,148,698 shares in the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Company Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.